Fundraising Fox

Avedro

also invests · investor profileAcquired

Waltham, US · Delaware corporation · 7 known investors

BiotechHealthtechMedical Devices

Founders & leadership

DF
David F. MullerFounder
BJ
Brian J. RobertsExecutive
RJ
Rhonda J. BraceyExecutive

Board

JH
Jason HongBoard director
JDJeff Dykan
Jeff DykaninBoard directorPartner at SCP Vitalife Partners
ANAnthony Natale
Anthony NataleinBoard directorManaging Partner at APERTURE Venture Partners
PJ
Philip J. FerneauBoard director
DB
David BerryBoard director
MB
Michael BighamBoard director
JM
Joseph MandatoBoard director
DC
Doug ColeBoard director
RP
Robert PalmisanoBoard director

Investors · 7

APERTURE Venture PartnersBoston · $1M – $5M
LAVHong Kong · $5M – $15M
Lilly Asia VenturesHong Kongvia Hongbo Lu · board
SCP Vitalife PartnersTel Aviv · $3M – $7Mvia Jeff Dykan · board
Third Point VenturesMenlo Park
HealthQuest CapitalreportedRedwood City
OrbiMedreportedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements

$93.3M disclosed across 5 rounds · 2011–2018

▶$25MraisedMay 2018 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan SilversteinDirector
  • Gilbert KlimanDirector
  • Garheng KongDirector
  • Reza ZadnoExecutive Officer, Director
  • Robert PalmisanoDirector
  • Hongbo LuDirector
  • Joseph MandatoDirector
  • Donald ZurbayDirector
Offering amount
$25M
Amount sold
$25M
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedMay 2017 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • REZA ZADNOExecutive Officer, Director
  • PAUL BAVIERExecutive Officer
  • GILBERT H. KLIMANDirector
  • JOSEPH MANDATODirector
  • JONATHAN SILVERSTEINDirector
  • TOM GRIFFINExecutive Officer
  • ROBERT PALMISANODirector
Offering amount
$12M
Amount sold
$12M
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.5MraisedNov 2015 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve BlinnExecutive Officer
  • David F. MullerExecutive Officer, Director
  • Jeff DykanDirector
  • M. Carl Johnson, IIIDirector
  • Brian J. RobertsExecutive Officer
  • Anthony NataleDirector
  • Robert PalmisanoDirector
  • Joseph MandatoDirector
  • Philip J. FerneauDirector
Offering amount
$32M
Amount sold
$16.5M
First sale
Nov 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.7MraisedApr 2015 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason HongDirector
  • David F. MullerExecutive Officer, Director
  • Jeff DykanDirector
  • Anthony NataleDirector
  • Robert PalmisanoDirector
  • Philip J. FerneauDirector
  • M. Carl Johnson, IIIDirector
  • David BerryDirector
  • Michael BighamDirector
  • Brian J. RobertsExecutive Officer
  • Joseph MandatoDirector
Offering amount
$17.6M
Amount sold
$13.7M
First sale
Nov 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26MraisedFeb 2012 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David F. MullerExecutive Officer, Director
  • Philip J. FerneauDirector
  • Anthony NataleDirector
  • Rhonda J. BraceyExecutive Officer
  • Doug ColeDirector
  • Jeff DykanDirector
  • Joseph MandatoDirector
  • M. Carl Johnson, IIIDirector
Offering amount
$26M
Amount sold
$26M
Finders' fees
$478.1K
Placement agents
BMO Capital Markets Corp.
First sale
Jun 2011
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Avedro Announces $25 Million in Funding to Fuel Innovation and Commercial Growthlavfund.com · Jan 2019Avedro raises $42M, opens plant to step up device rollout | Fierce Biotechfiercebiotech.com · Apr 2017Avedro raises $42m, opens new Mass-based manufacturing facility - MassDevicemassdevice.com · Apr 2017Avedro raises $32 mlnventurecapitaljournal.com · Nov 2015Avedro, Inc. Raises $43 Million in Pursuit of FDA Approval for Lasik Device - BioSpacebiospace.com · Mar 2013Avedro Raises $25M In VC Funding | Institutional Investorinstitutionalinvestor.com · Jul 2011

Frequently asked questions

Who founded Avedro?
Avedro was founded by David F. Muller.
Who are Avedro's investors?
Avedro's investors include APERTURE Venture Partners, LAV, Lilly Asia Ventures, SCP Vitalife Partners, Third Point Ventures, HealthQuest Capital, OrbiMed.
How much funding has Avedro raised?
Avedro has disclosed $93.3M raised across 5 rounds.
Where is Avedro headquartered?
Avedro is headquartered in Waltham, US.